Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03520530 · ClinicalTrials.gov registry record · NA

Mouth Guard Use in the Second Stage of Labor

A NA study of Labor Long and Dystocia; Fetal, sponsored by Christiana Care Health Services.

Completed
Registry status
NA
Development phase
154
Enrollment target
1
Study location

NCT03520530: Completed NA study of Labor Long and Dystocia; Fetal, sponsored by Christiana Care Health Services.

NCT03520530 is a NA study of Labor Long and Dystocia; Fetal that has completed, run by Christiana Care Health Services. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03520530, a NA study of Labor Long and Dystocia; Fetal, has completed, sponsored by Christiana Care Health Services.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

Shortening the second stage of labor, the time spent pushing the baby out, is important for positive mother and infant's outcomes. Lack of progress of labor for any reason is the most common reason for cesarean section in women having their first baby and the second most common reason for cesarean section in women who have already had a baby. In 2014, a large study done across the United States showed increases in complications in both mother and infant when pushing was prolonged, including uterine infection, postpartum hemorrhage, more extensive vaginal tearing, shoulder dystocia, 5 minute Apgar score less than 4, infant admission to Neonatal Intensive Care Unit and neonatal infections. Therefore, the challenge is to consider alternative practices in order to maximize a mother's chance of a vaginal delivery and minimize these associated risks to both mother and baby. Mouth guards are used primarily in contact sports, and have been demonstrated to reduce or prevent injury to the teeth. Additionally, it has been proposed that wearing a mouth guard increases the strength of different muscle groups. A recent randomized controlled pilot study including women with their first pregnancy using a dental support device (DSD) during the second stage of labor evaluated the length of the second stage and outcomes. They found a significant decrease of 38% in the length of pushing time in the group that used a DSD. Additionally, there was a decreased rate of cesarean section in this group, however a p-value was not reported. This study only included 64 patients. A second, larger trial did not find a significant difference in pushing time, however the rate of interventions such as a vacuum or forceps-assisted vaginal delivery and cesarean section were much higher in the control group due to prolonged pushing. The results of the second study are contradictory in nature, yet the researchers do not provide hypotheses into why this may be. It is clear from the previously mentioned s

Primary Outcome

Time in minutes

Interventions

  • DEVICE Mouth Guard

Study Locations (1)

Delaware

  • Christiana Care Health System - Newark

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2018-05-09
Est. Completion 2019-12-01
Phase NA
Christiana Care Health Services

82 total trials

What the finished NCT03520530 record still lists

NCT03520530 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Labor Long appearing as the primary indexed condition, and to 1 intervention - of which Mouth Guard is the first listed.

NCT03520530 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT03520530 about?

NCT03520530 is a clinical study titled "Mouth Guard Use in the Second Stage of Labor". Shortening the second stage of labor, the time spent pushing the baby out, is important for positive mother and infant's outcomes. Lack of progress of labor for any reason is the most common reason for cesarean section in women having their first baby and the second most common reason for cesarean s...

What is the current status of trial NCT03520530?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2018-05-09. Estimated completion is 2019-12-01.

What conditions does trial NCT03520530 study?

This clinical trial studies the following conditions: Labor Long, Dystocia; Fetal, Cesarean Section, Affecting Fetus or Newborn.

What interventions are being tested in trial NCT03520530?

The interventions under investigation include: Mouth Guard (DEVICE).

Who is sponsoring clinical trial NCT03520530?

This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03520530 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Long

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03520530's enrollment target sits among peer trials

154 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03520530, the US trial registry maintained by the National Library of Medicine. NCT03520530 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.